Stuart A. Grossman, MD
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Stuart A. Grossman, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:18 UTC. Open this list on ClinicalTrials.gov
- N/ANCT04895553 · Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to ApixabanSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · terminated · Glioma, Malignant
- Ph2NCT03973918 · Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGGSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · terminated · High Grade Glioma, BRAF V600E, BRAF V600K
- Ph1NCT03971734 · Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade GliomasSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · terminated · High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma
- N/ANCT02041611 · Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade GliomasSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · High Grade Glioma
- N/ANCT01653834 · Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade GliomasSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Glioblastoma
- N/ANCT00999622 · Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial AstrocytomaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Brain and Central Nervous System Tumors, Infection · study chair
- N/ANCT00899951 · Studying Fentanyl in Patients With CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · terminated · Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Leukemia · principal investigator
- N/ANCT00897611 · Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant GliomaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · High Grade Glioma · study chair
- N/ANCT00670917 · Magnetic Acupressure in Reducing Pain in Cancer Patients Undergoing Bone Marrow Aspiration and BiopsySidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Hematopoietic/Lymphoid Cancer, Pain · principal investigator
- N/ANCT00471653 · Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation TherapySidney Kimmel Comprehensive Cancer Center at Johns Hopkins · terminated · Brain and Central Nervous System Tumors, Thrombocytopenia · study chair
- N/ANCT00463008 · Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade GliomaNew Approaches to Brain Tumor Therapy Consortium · completed · Brain and Central Nervous System Tumors · unknown
- Ph1/Ph2NCT00404248 · Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade GliomaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Brain and Central Nervous System Tumors · study chair
- Ph1NCT00401024 · Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant GliomaSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Brain and Central Nervous System Tumors · study chair
- Ph3NCT00267332 · Modafinil in Opioid Induced SedationSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · terminated · Cancer, Pain
- N/ANCT00253669 · Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed GliomasSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · completed · Brain and Central Nervous System Tumors, Thromboembolism · principal investigator
- Ph2NCT00238277 · Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma MultiformeSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · terminated · Brain and Central Nervous System Tumors · principal investigator
- Ph2NCT00082797 · High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma MultiformeEastern Cooperative Oncology Group · completed · Brain and Central Nervous System Tumors · study chair
- Ph2NCT00068770 · Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RTSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · terminated · Brain and Central Nervous System Tumors · study chair
- Ph1/Ph2NCT00004004 · Procarbazine in Treating Patients With Recurrent Brain TumorNew Approaches to Brain Tumor Therapy Consortium · completed · Brain and Central Nervous System Tumors · study chair
- Ph1NCT00014521 · Karenitecin in Treating Patients With Recurrent Malignant GliomaNational Cancer Institute (NCI) · completed · Brain and Central Nervous System Tumors · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:18 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Adult Brain Tumor Consortium (ABTC)UM1CA137443 · NCI · JOHNS HOPKINS UNIVERSITY · PI STUART A GROSSMAN · fiscal years 2014 to 2020Named on NCT03973918, NCT03971734
- U01CA062475RePORTER returned no project for this number; it is shown as the registry gives it.
- Cancer Chemical and Structural BiologyP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI James M. Berger · fiscal years 2013 to 2026
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.